Advertisement ViOptix secures $12.2 million in series D financing - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

ViOptix secures $12.2 million in series D financing

ViOptix has raised $12.2 million in a series D round of financing. The round was led by Channel Medical Partners, a venture investor in emerging growth medical technology companies.

In addition to Channel Medical Partners, other investors include Lincoln Funds International and existing investors Canadian Medical Discoveries Fund and Morningside Technology Ventures. In conjunction with this financing, Gregory Shearer, founder and principal of Channel Medical Partners, will join the ViOptix board of directors. Merriman Curhan & Ford served as financial advisors to ViOptix.

Proceeds from the financing will be used to develop and launch additional clinical applications from the core platform technology and expand the company’s presence in the microsurgery market. Funding will also support the company’s clinical trials program, in-licensing activities and international expansion.